Beauty Health Gross Profit 2020-2025 | SKIN
Beauty Health gross profit from 2020 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Beauty Health Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $182 |
| 2023 | $155 |
| 2022 | $249 |
| 2021 | $179 |
| 2020 | $67 |
| 2019 | $107 |
| Beauty Health Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $49 |
| 2024-12-31 | $52 |
| 2024-09-30 | $41 |
| 2024-06-30 | $41 |
| 2024-03-31 | $48 |
| 2023-12-31 | $46 |
| 2023-09-30 | $-13 |
| 2023-06-30 | $68 |
| 2023-03-31 | $54 |
| 2022-12-31 | $66 |
| 2022-09-30 | $61 |
| 2022-06-30 | $70 |
| 2022-03-31 | $51 |
| 2021-12-31 | $53 |
| 2021-09-30 | $46 |
| 2021-06-30 | $47 |
| 2021-03-31 | $32 |
| 2020-12-31 | |
| 2020-09-30 | $21 |
| 2020-06-30 | $4 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.193B | $0.334B |
| The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.127B | 26.17 |
| CVS Health (CVS) | United States | $79.232B | 9.85 |
| Elevance Health (ELV) | United States | $61.847B | 8.32 |
| Cencora (COR) | United States | $55.889B | 19.44 |
| DiDi Global (DIDIY) | China | $23.438B | 24.90 |
| Labcorp Holdings (LH) | United States | $21.888B | 17.27 |
| Natera (NTRA) | United States | $18.376B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.072B | 0.00 |
| ICON (ICLR) | Ireland | $13.441B | 12.93 |
| CochLear (CHEOY) | Australia | $13.183B | 0.00 |
| Solventum (SOLV) | United States | $12.410B | 13.14 |
| Medpace Holdings (MEDP) | United States | $11.886B | 31.46 |
| Revvity (RVTY) | United States | $10.400B | 18.04 |
| Viatris (VTRS) | United States | $10.340B | 3.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.699B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.198B | 16.06 |
| HealthEquity (HQY) | United States | $7.874B | 34.49 |
| Avantor (AVTR) | United States | $7.741B | 11.36 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.133B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.776B | 32.14 |
| Amplifon S.p.A (AMFPF) | Italy | $3.890B | 21.30 |
| BrightSpring Health Services (BTSG) | United States | $3.453B | 26.54 |
| Sotera Health (SHC) | United States | $3.165B | 17.98 |
| GeneDx Holdings (WGS) | United States | $2.899B | 66.84 |
| Surgery Partners (SGRY) | United States | $2.727B | 35.47 |
| Alignment Healthcare (ALHC) | United States | $2.568B | 0.00 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Concentras Parent (CON) | United States | $2.497B | 14.43 |
| Progyny (PGNY) | United States | $1.928B | 42.43 |
| Premier (PINC) | United States | $1.751B | 13.29 |
| PACS (PACS) | United States | $1.618B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
| Ardent Health (ARDT) | United States | $1.462B | 6.23 |
| Teladoc Health (TDOC) | United States | $1.226B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.195B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.029B | 7.83 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.882B | 302.50 |
| Agilon Health (AGL) | United States | $0.704B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.683B | 6.40 |
| CareDx (CDNA) | United States | $0.680B | 10.63 |
| Performant Healthcare (PHLT) | United States | $0.598B | 0.00 |
| Embecta (EMBC) | United States | $0.582B | 3.92 |
| Nutex Health (NUTX) | United States | $0.467B | 7.06 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| LifeMD (LFMD) | United States | $0.452B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| Omada Health (OMDA) | $0.448B | 0.00 | |
| So-Young (SY) | China | $0.438B | 0.00 |
| SBC Medicals (SBC) | United States | $0.433B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.423B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.416B | 0.00 |
| Oncology Institute (TOI) | United States | $0.333B | 0.00 |
| Enhabit (EHAB) | United States | $0.330B | 27.17 |
| DocGo (DCGO) | United States | $0.136B | 22.17 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| KindlyMD (NAKA) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |